Frank Takkinen
Stock Analyst at Lake Street
(1.06)
# 3,790
Out of 5,067 analysts
65
Total ratings
30.51%
Success rate
-13.59%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LUNG Pulmonx | Maintains: Buy | $8 → $4 | $1.56 | +156.41% | 3 | Oct 28, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $5 → $7 | $7.49 | -6.54% | 6 | Oct 21, 2025 | |
| RCEL AVITA Medical | Downgrades: Hold | $8 → $4 | $3.75 | +6.67% | 1 | Oct 17, 2025 | |
| ELUT Elutia | Maintains: Buy | $8 → $6 | $0.60 | +900.17% | 4 | Sep 10, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.5 → $2 | $1.11 | +80.18% | 2 | Aug 14, 2025 | |
| INSP Inspire Medical Systems | Maintains: Buy | $270 → $150 | $117.29 | +27.89% | 2 | Aug 5, 2025 | |
| ANGO AngioDynamics | Initiates: Buy | $24 | $12.30 | +95.12% | 1 | Jul 16, 2025 | |
| BBNX Beta Bionics | Assumes: Buy | $30 | $31.40 | -4.46% | 1 | Jun 12, 2025 | |
| NOTV Inotiv | Maintains: Buy | $6 → $5 | $0.80 | +522.74% | 7 | May 8, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $19 → $14 | $9.84 | +42.28% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $15 | $9.56 | +56.90% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $28.39 | +5.67% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $16.88 | +54.03% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $14.40 | +108.33% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $5 | $4.89 | +2.25% | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $3.73 | +436.91% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.96 | +155.10% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.14 | +601.75% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $45.81 | -34.51% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $0.77 | +680.54% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.36 | +69.49% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $16.26 | -26.20% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $3.87 | +132.56% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $2.25 | +611.11% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.32 | +2,754.05% | 2 | Jan 18, 2023 |
Pulmonx
Oct 28, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.56
Upside: +156.41%
Sight Sciences
Oct 21, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $7.49
Upside: -6.54%
AVITA Medical
Oct 17, 2025
Downgrades: Hold
Price Target: $8 → $4
Current: $3.75
Upside: +6.67%
Elutia
Sep 10, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $0.60
Upside: +900.17%
Hyperfine
Aug 14, 2025
Maintains: Buy
Price Target: $1.5 → $2
Current: $1.11
Upside: +80.18%
Inspire Medical Systems
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $117.29
Upside: +27.89%
AngioDynamics
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $12.30
Upside: +95.12%
Beta Bionics
Jun 12, 2025
Assumes: Buy
Price Target: $30
Current: $31.40
Upside: -4.46%
Inotiv
May 8, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $0.80
Upside: +522.74%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $9.84
Upside: +42.28%
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $9.56
Upside: +56.90%
Mar 17, 2025
Initiates: Buy
Price Target: $30
Current: $28.39
Upside: +5.67%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $16.88
Upside: +54.03%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $14.40
Upside: +108.33%
Jan 14, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $4.89
Upside: +2.25%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $3.73
Upside: +436.91%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $1.96
Upside: +155.10%
Aug 13, 2024
Maintains: Buy
Price Target: $14 → $8
Current: $1.14
Upside: +601.75%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $45.81
Upside: -34.51%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $0.77
Upside: +680.54%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.36
Upside: +69.49%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $16.26
Upside: -26.20%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $3.87
Upside: +132.56%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $2.25
Upside: +611.11%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.32
Upside: +2,754.05%